12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
The article reports on the after-market session movements of various healthcare stocks. Notable gainers include SenesTech, Venus Concept, and AtriCure, while Tyra Biosciences, DaVita, and 10x Genomics were among the losers. AtriCure, DaVita, and 10x Genomics released their Q3 earnings.
October 29, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ABVC BioPharma's stock rose by 5.33% in the after-market session, reflecting positive investor sentiment.
The stock's rise indicates positive sentiment, which could continue to drive the price up in the short term.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
AtriCure's stock rose by 5.33% following the release of its Q3 earnings, indicating a positive market reaction.
The stock's increase following earnings suggests positive results or outlook, likely leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
LogicMark's stock increased by 6.3% in the after-market session, suggesting positive investor sentiment.
The upward movement suggests investors are optimistic, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
Marinus Pharma's stock rose by 5.37% in the after-market session, indicating positive market sentiment.
The stock's increase suggests positive sentiment, which could lead to further short-term gains.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
SenesTech's stock increased by 9.9% in the after-market session, indicating positive investor sentiment.
The significant price increase suggests strong investor interest or positive news, likely leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Venus Concept's stock rose by 8.82% in the after-market session, reflecting a positive market reaction.
The stock's rise indicates positive sentiment, which could continue to drive the price up in the short term.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Aptevo Therapeutics' stock decreased by 7.7% in the after-market session, indicating negative investor sentiment.
The stock's decline suggests negative sentiment, which could lead to further short-term declines.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Cyclerion Therapeutics' stock declined by 7.93% in the after-market session, reflecting negative investor sentiment.
The stock's decline suggests negative sentiment, which could lead to further short-term declines.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
DaVita's stock decreased by 8.25% following the release of its Q3 earnings, indicating a negative market reaction.
The stock's decline following earnings suggests disappointing results or outlook, likely leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Reshape Lifesciences' stock decreased by 7.09% in the after-market session, reflecting negative investor sentiment.
The stock's decline suggests negative sentiment, which could lead to further short-term declines.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
10x Genomics' stock decreased by 6.59% following the release of its Q3 earnings, indicating a negative market reaction.
The stock's decline following earnings suggests disappointing results or outlook, likely leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Tyra Biosciences' stock declined by 11.2% in the after-market session, indicating negative investor sentiment.
The significant price drop suggests negative sentiment or news, likely leading to further short-term declines.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80